In patients with high concentrations of sdLDL, the risk of CHD is best assessed by apoB concentrations (thus including apoB100 and apoB48), as the presence of sdLDL is not reflected by elevated LDL-C concentrations. The gene discussed is APOB; the disease is coronary artery disorder.